Home » KineMed

KineMed

Jan 04, 2016

KineMed Collaborates With Pfizer on Proteomics Biomarkers

Building on the companies' existing relationship, the deal licenses KineMed's proteomics platform to the pharmaceuticals giant for CDx development.

Jun 02, 2015

KineMed, Pronutria Ink R&D Collaboration

The partners will use KineMed's proteomics platform to evaluate the effect of biologics developed by Pronutria for metabolic and other diseases.

Jun 06, 2014

In Brief This Week: Agilent Technologies; Diagnocure; KineMed, Pfizer; PositiveID; SomaLogic

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income.

Jun 06, 2014

KineMed, Pfizer Renew Metabolic Disease Research Collaboration

Premium

NEW YORK (GenomeWeb News) – KineMed this week announced the renewal of its non-exclusive research collaboration with Pfizer into metabolic disease, and type 2 diabetes in particular.

May 23, 2014

KineMed and CHDI Foundation Extend Collaboration on Huntington's Disease Biomarkers

Premium

NEW YORK (GenomeWeb News) – KineMed said this week that it has extended its collaboration with the CHDI Foundation on research into biomarkers for Huntington's disease.

May 23, 2014

People in the News: Patrick Doyle, Dominique Grau, Jean Halloran

Premium

KineMed has tapped Patrick Doyle to be executive VP and chief business officer. In the post, he will head corporate development activities, including licensing and strategic partnerships.

May 19, 2014

KineMed, CHDI Foundation Extend Huntington's Disease Collaboration

NEW YORK (GenomeWeb) – KineMed and CHDI Foundation today said they are extending their collaboration to characterize and track the pathogenesis of Huntington's disease and to evaluate possible therapeutic interventions.

Oct 15, 2013

KineMed Inks Deal with Amgen to Study Brain Proteins Linked to Neurodegenerative Disease

NEW YORK (GenomeWeb News) – KineMed said today that it has entered an agreement with Amgen to apply its mass spec-based Dynamic Proteomics platform to the study of brain protein homeostasis in neurodegenerative disease.

Sep 19, 2013

KineMed Wins $225K SBIR Contract to Develop Myocardial Fibrosis Biomarkers

NEW YORK (GenomeWeb News) – KineMed said today that it has received a $225,000 Phase I Small Business Innovation Research contract from the National Heart, Lung, and Blood Institute for research into biomarkers for the early detection of myocardial fibrosis.

Aug 23, 2013

People in the News: Thomas Bachmann, Joseph Eggler, and More

Premium

Bruker has appointed Thomas Bachmann to be president of its Bruker BioSpin Group.

Pages

The Scan

Marks Left on the Genome

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

Cost and Coverage of Gene Therapies

The Wall Street Journal looks into the cost of new gene therapies.

Mosquito Population Crash

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

This Week in PNAS

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.